Manatt investigations, compliance and white collar defense partner Richard Hartunian spoke with Law360 about the proposed $8 billion settlement in the Purdue Pharma opioid case. In the article, Hartunian discussed the potential implications of this deal, noting that the size and scope of the settlement sends a clear message to pharmaceutical industry stakeholders. “Their business efforts in this industry are going to get very serious continuing and ongoing scrutiny by government enforcement agencies, and they should act accordingly,” Hartunian said.
Read the article here.